Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Most cited article(s)

  • Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
    You have access
    Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
    Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
    Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  • <sup>68</sup>Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study
    Open Access
    68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study
    Ling Chen, Shan Zheng, Linying Chen, Sunwang Xu, Kunlin Wu, Lingjun Kong, Jiajie Xue, Xiangjin Chen, Weibing Miao and Youzhi Zhu
    Journal of Nuclear Medicine December 1, 2023, 64 (12) 1899-1905; DOI: https://doi.org/10.2967/jnumed.123.266079
  • Can Internal Carotid Arteries Be Used for Noninvasive Quantification of Brain PET Studies?
    You have access
    Can Internal Carotid Arteries Be Used for Noninvasive Quantification of Brain PET Studies?
    Laura Providência, Chris W.J. van der Weijden, Philipp Mohr, Joyce van Sluis, Johannes H. van Snick, Riemer H.J.A. Slart, Rudi A.J.O. Dierckx, Adriaan A. Lammertsma and Charalampos Tsoumpas
    Journal of Nuclear Medicine April 1, 2024, 65 (4) 600-606; DOI: https://doi.org/10.2967/jnumed.123.266675
  • SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [<sup>177</sup>Lu]Lu-DOTATATE
    You have access
    SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [177Lu]Lu-DOTATATE
    Johan Blakkisrud, Avery B. Peterson, Scott J. Wildermann, Griffen Kingkiner, Ka Kit Wong, Chang Wang, Kirk A. Frey, Caroline Stokke and Yuni K. Dewaraja
    Journal of Nuclear Medicine May 1, 2024, 65 (5) 753-760; DOI: https://doi.org/10.2967/jnumed.123.266843
  • Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET
    You have access
    Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET
    Stanley Fayn, A. Paden King, Nicholas T. Gutsche, Zhijian Duan, Jesse Buffington, Colleen P. Olkowski, Ying Fu, Jessica Hong, Deepak Sail, Kwamena E. Baidoo, Rolf E. Swenson, Ross W. Cheloha, Mitchell Ho, Peter L. Choyke and Freddy E. Escorcia
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 1017-1023; DOI: https://doi.org/10.2967/jnumed.122.265171
  • Performance Characteristics of the NeuroEXPLORER, a Next-Generation Human Brain PET/CT Imager
    Open Access
    Performance Characteristics of the NeuroEXPLORER, a Next-Generation Human Brain PET/CT Imager
    Hongdi Li, Ramsey D. Badawi, Simon R. Cherry, Kathryn Fontaine, Liuchun He, Shannan Henry, Ansel T. Hillmer, Lingzhi Hu, Nikkita Khattar, Edwin K. Leung, Tiantian Li, Yusheng Li, Chi Liu, Peng Liu, Zhenrui Lu, Stanislaw Majewski, David Matuskey, Evan D. Morris, Tim Mulnix, Negar Omidvari, Suranjana Samanta, Aaron Selfridge, Xishan Sun, Takuya Toyonaga, Tommaso Volpi, Tianyi Zeng, Terry Jones, Jinyi Qi and Richard E. Carson
    Journal of Nuclear Medicine August 1, 2024, 65 (8) 1320-1326; DOI: https://doi.org/10.2967/jnumed.124.267767
  • An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 3: Contribution from Calculating Absorbed Dose from Time-Integrated Activity
    Open Access
    An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 3: Contribution from Calculating Absorbed Dose from Time-Integrated Activity
    Julia Brosch-Lenz, Sara Kurkowska, Eric Frey, Yuni K. Dewaraja, John Sunderland and Carlos Uribe
    Journal of Nuclear Medicine August 1, 2024, 65 (8) 1166-1172; DOI: https://doi.org/10.2967/jnumed.123.267293
  • You have access
    The Future of Nuclear Medicine in the United States
    Michael M. Graham
    Journal of Nuclear Medicine September 1, 2023, 64 (9) 1352-1353; DOI: https://doi.org/10.2967/jnumed.122.265314
  • Open Access
    177Lu-PSMA (R)Evolution in Cancer Care: Is It Really Happening?
    Andreas Poschenrieder, Jasminka Taleska and Leonhard Schaetz
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1340-1342; DOI: https://doi.org/10.2967/jnumed.124.267951
  • You have access
    Is 212Pb Really Happening? The Post-177Lu/225Ac Blockbuster?
    Richard Zimmermann
    Journal of Nuclear Medicine February 1, 2024, 65 (2) 176-177; DOI: https://doi.org/10.2967/jnumed.123.266774

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
SNMMI

© 2025 SNMMI

Powered by HighWire